Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FDC2Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,726
Award facts
- Contract value 100% obligated
- $24,726.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,726.12 to AmerisourceBergen Drug Corp for the supply of Cosentyx Unoready 300 mg pen 2ml, a pharmaceutical product used in military and federal healthcare systems. The contract was awarded on January 28, 2026, with an ultimate completion date of January 29, 2026, and represents a firm fixed-price procurement with no set-aside designation. The awardee, AmerisourceBergen Drug Corp, is headquartered in Conshohocken, Pennsylvania, and serves as a critical vendor for federal medical procurement needs. The company operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which functions as the parent organization in this contracting relationship.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, and related healthcare products. The contract supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through a flexible procurement mechanism. All of AmerisourceBergen's federal awards are competitively awarded on a full and open basis, demonstrating the company's capability to meet federal procurement requirements.
Quick answers
Who was awarded contract SPE2DR26FDC2Y?
SPE2DR26FDC2Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FDC2Y worth?
The government has obligated $24,726 on SPE2DR26FDC2Y.
Is contract SPE2DR26FDC2Y an order under another contract?
Yes. SPE2DR26FDC2Y is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDC2Y competed?
The extent of competition for SPE2DR26FDC2Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award